A groundbreaking shift in Canadian drug policy has happened, as the regulators allow the legalization of psilocybin hallucinogens for therapeutic treatment. Until now, these substances were severely restricted, but a growing body of studies suggests they may offer benefits for emotional illnesses like PTSD. This change represents a major step towar